摘要
目的和方法:对糖尿病Ⅰ组(HbA1c为706%±060%)Ⅱ组(HbA1c为1197%±165%)各7例及对照组(HbA1c为485%±020%)6例的高密度脂蛋白(highdensitylipoprotein,HDL)糖化进行检测,同时将HDL抗血清提纯为抗HDLIgG并用辣根过氧化物酶(horserdishperioxidase,HRP)标记。用酶联免疫受体法测定HDL与培养的人胚肺成纤维细胞(humanlungfibroblast,HLF)受体特异结合。结果:Ⅰ、Ⅱ组及对照组糖化值分别为3926±810、7294±640和2040±110Glycogroup/HDL,Ⅰ、Ⅱ组HDL的细胞受体特异结合低于对照组(P<001),Ⅱ组低于Ⅰ组(P<001)。结论:糖尿病患者HDL糖化高于正常人。
AIM and METHODS: The glycosylation of high density lipoproteins(HDL)from diabetic patient group I(HbA 1c =7.06%±0.60%, n =7).Ⅱ(HbA 1c =11.95%±1.65%, n =7)and control group(HbA 1c =4.85%±0.20%, n =6)was measured.Anti-HDL IgG was obtained from anti-serum to human HDL and labelled by horserdish perioxidase (HRP).The specific binding of HDL to human fibroblasts(HLF)receptors was measured using enzyme linked immunoreceptor assay. RESULTS: The glycosylated amount of HDL fromⅠ、Ⅱand control groups were 39.26±8.10,72.94±6.40,and 20.40±1.10 glycogroups/HDL,respecively.The specific binding of HDL to HLF receptors in group ⅠandⅡwas lower than that in control group,groupⅡwas lower than groupⅠ. CONCLUSLN: The glycosylation of HDL of diabetic patients is higher than that of normal subjects but lower in its specific binding to cultured cell receptors.
出处
《中国病理生理杂志》
CAS
CSCD
北大核心
1998年第3期239-242,共4页
Chinese Journal of Pathophysiology
基金
国家教委博士点科研基金